Rhythm Pharmaceuticals Inc

RYTM

Equity

ISIN null / Valor 25337263

NASDAQ (2026-03-06)

USD 93.52+2.25%

Rhythm Pharmaceuticals Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Rhythm Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare genetic disorders of obesity, specifically those related to the melanocortin-4 receptor (MC4R) pathway. These disorders are distinct from general obesity and are characterized by early-onset, severe obesity and hyperphagia, a condition marked by an insatiable hunger. The company's primary focus is on addressing these rare MC4R pathway impairments to provide targeted therapeutic solutions for patients suffering from these debilitating conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

81.1%1Y

327%3Y

260%5Y

Performance

55.7%1Y

55.6%3Y

74.2%5Y

Volatility

6386 M

Market cap (USD)

629,431

Daily traded volume (Shares)

56.78 / 55.07

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

4.00

Innovation:

5.00

Society:

5.00

Nature:

2.00

Adrian Pusz

Switzerland, 20 Apr 2025

Rhythm develops what will always be needed - rare disease therapies

EQUITIES OF THE SAME SECTOR

M1 Kliniken AG

M1 Kliniken AG Valor: 29694419

Annual Return

-50%0%+50%

Risk level

110

-2.14%EUR 15.54

Summit Therapeutics Inc

Summit Therapeutics Inc Valor: 56903013

Annual Return

-50%0%+50%

Risk level

110

1.14%USD 15.11

Heidelberg Pharma AG

Heidelberg Pharma AG Valor: 24937540

Annual Return

-50%0%+50%

Risk level

110

0.33%EUR 3.07

Nelnet Inc

Nelnet Inc Valor: 1665235

Annual Return

-50%0%+50%

Risk level

110

-0.79%USD 130.78

CG Oncology Inc

CG Oncology Inc Valor: 131996952

Annual Return

-50%0%+50%

Risk level

110

2.50%USD 61.88

Masimo Corp

Masimo Corp Valor: 493578

Annual Return

-50%0%+50%

Risk level

110

-0.02%USD 175.42

Kenvue Inc

Kenvue Inc Valor: 124280948

Annual Return

-50%0%+50%

Risk level

110

0.77%USD 18.39

Galenica Ltd.

Galenica Ltd. Valor: 36067446

Annual Return

-50%0%+50%

Risk level

110

0.21%CHF 93.45

Cencora Inc

Cencora Inc Valor: 1212868

Annual Return

-50%0%+50%

Risk level

110

-0.23%USD 358.46

PolyPeptide Group Ltd

PolyPeptide Group Ltd Valor: 111076085

Annual Return

-50%0%+50%

Risk level

110

-4.43%CHF 23.75

Logos provided by Clearbit

Rhythm Pharmaceuticals Inc

RYTM

ISIN null / Valor 25337263

Rhythm Pharmaceuticals Inc UMushroom community rating:

Adrian Pusz

Rhythm Pharmaceuticals Inc
UMushroom community rating: